Synthetic Cannabinoids Urine Testing
We can confidently say we're at the forefront of researching and identifying synthetic cannabinoids. We were the first lab in the world to develop a urine-based metabolite test for "synthetic marijuana."
4 to 100 times stronger than marijuana, users often turn to these herbal smoking products marketed under brand names such as K2, K3 Legal, Syn, Spice, and many others to avoid detection by standard drug tests.
In July 2012, the DEA banned 15 synthetic cannabinoids, citing numerous calls to poison control center around the nation. However, newer generation compounds continue to emerge—making it more vital than ever to target synthetic marijuana.
Features & Benefits
-
Accurately identifies 37 synthetic cannabinoids and their metabolites
-
Confirmation performed on advanced QTRAP® liquid chromatography/tandem mass spectrometry (LC/MS/MS) equipment, providing definitive biomarker test results
-
Average window of detection is 72 hours following a single low dose; in case of chronic use the window may be much longer
View service documentation online or download Adobe PDF files to ensure you have what you need to conduct effective drug test.
| Test panel and Cutoff levels |
6473: Urine Synthetic Cannabinoid Test Panel—
LOD between 0.1 – 0.5 ng/mL for all analytes. |
| Drug Screening Panel |
Methodology |
Cutoff
Level |
| AKB-48 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AM-1248 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AM-2201 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AM-694 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-018 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-019 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-073 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-081 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-122 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-200 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-203 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-210 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-250 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-398 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| MAM-2201 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| RCS-4 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| RCS-8 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| UR-144 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| XLR-11 (and/or metabolites) |
LC-MS/MS |
Qualitative |
8474: Premium Urine Synthetic Cannabinoid Test Panel—
LOD between 0.1 – 0.5 ng/mL for all analytes. |
| Drug Screening Panel |
Methodology |
Cutoff
Level |
| 5-fluoro-AB-PINACA (and/or metabolites) |
LC-MS/MS |
Qualitative |
| 5-fluoro-ADBICA (and/or metabolites) |
LC-MS/MS |
Qualitative |
| 5-fluoro-ADB-PINACA (and/or metabolites) |
LC-MS/MS |
Qualitative |
| 5-fluoro-AKB-48 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| 5-fluoro-AMB (and/or metabolites) |
LC-MS/MS |
Qualitative |
| 5-fluoro-PB-22 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AB-CHMINACA (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AB-FUBINACA (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AB-PINACA (and/or metabolites) |
LC-MS/MS |
Qualitative |
| ADBICA (and/or metabolites) |
LC-MS/MS |
Qualitative |
| ADB-PINACA (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AKB-48 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AM-1248 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AM-2201 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| AM-694 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| BB-22 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| FDU-PB-22 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| FUB-144 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| FUB-AMB (and/or metabolites) |
LC-MS/MS |
Qualitative |
| FUB-PB-22 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-018 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-019 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-073 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-081 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-122 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-200 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-203 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-210 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-250 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| JWH-398 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| MAM-2201 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| PB-22 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| RCS-4 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| RCS-8 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| THJ-2201 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| UR-144 (and/or metabolites) |
LC-MS/MS |
Qualitative |
| XLR-11 (and/or metabolites) |
LC-MS/MS |
Qualitative |
|
